One group of Chan Zuckerberg Biohub Network researchers are using advanced microfluidics and deep learning to decode tissue signaling dynamics, driving new insights for treating autoimmune diseases and cancer. From biomedical research to biomanufacturing, Illinois is driving innovation #BeyondBiology
The Microtissue Signaling Dynamics Group at CZ Biohub Chicago is developing advanced microfluidic platforms to quantify the progress of immune signaling and response dynamics in microtissue. They aim to develop intuitive and universal models for the signaling dynamics within tissues. Learn more about their projects, led by Biobub Fellow Minjun Son: https://czi.co/489YW4m